Vor Biopharma Inc
VOR
Market Cap$45.92M
Close$
$0.73
31.2% downside
Current Fair Value
31.2% downsideOvervalued by 31.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $45.92 Million |
|---|---|
| Enterprise Value | $30.38 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.75 |
| Beta | -0.35 |
| Outstanding Shares | 68,299,170 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.39 |
|---|---|
| PEG | -7.11 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.25 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.14 |
| Debt to Equity | 0.52 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Vor Biopharma Inc
88 employeesVor Biopharma is a cell therapy company that aims to transform the lives of cancer patients by pioneering engineered hematopoietic stem cell (eHSC) therapies to create next-generation, treatment-resistant transplants that unlock the pote...